Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes

Inclusion Criteria: * Type 2 diabetes * Duration of diabetes for at least 1 year * Body Mass Index (BMI) maximum 30.0 kg/m\^2 * HbA1c maximum 10.0% Exclusion Criteria: * Recurrent severe hypoglycaemia * Proliferative or preproliferative retinopathy diagnosed within the last 12 weeks or laser therapy for retinopathy within the last 12 weeks * Impaired hepatic function * Impaired renal function * Cardiac problems * Uncontrolled treated / untreated hypertension * Hepatitis B surface antigen, Hepatitis C antibodies or HIV (human immunodeficiency virus) antibodies positive * Total daily insulin dose exceeding 40 IU * Treatment with OHAs (oral hypoglycaemic agents) or insulin preparations twice or more frequently a day * Treatment with OHAs or insulin preparations once a day later than noon * Subjects who smoke more than 15 cigarettes per day